Point-of-care antibiotic susceptibility testing for gonorrhoea: Improving therapeutic options and sparing the use of cephalosporins

  • Sadiq S
  • Dave J
  • Butcher P
  • 19


    Mendeley users who have this article in their library.
  • 12


    Citations of this article.


Point-of-care susceptibility testing for gonococcus allows individualised antibiotic treatment despite high local resis- tance rates, sparing cephalosporin use.
< Most known genetic markers of resistance currently have a limited role in predicting phenotypic resistance, but evidence suggests their absence can accurately predict susceptibility.
< Modern microengineered nanotechnologies may provide the basis for point-of-care susceptibility testing in the near future. < Rapid tests remain dependent upon surveillance programmes to monitor for new emerging resistant strains of gonorrhoea.

Get free article suggestions today

Mendeley saves you time finding and organizing research

Sign up here
Already have an account ?Sign in

Find this document


  • S. T. Sadiq

  • J. Dave

  • P. D. Butcher

Cite this document

Choose a citation style from the tabs below

Save time finding and organizing research with Mendeley

Sign up for free